
Exelixis Inc
EXEL
EXEL: Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
moreShow EXEL Financials
Recent trades of EXEL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by EXEL's directors and management
Government lobbying spending instances
-
$460,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues
-
$440,000 Apr 25, 2023 Issue: Taxation/Internal Revenue Code Health Issues
-
$330,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues
-
$320,000 Oct 19, 2022 Issue: Taxation/Internal Revenue Code Health Issues
-
$300,000 Jul 19, 2022 Issue: Taxation/Internal Revenue Code Health Issues
-
$290,000 Apr 19, 2022 Issue: Health Issues
-
$280,000 Jan 19, 2022 Issue: HEALTH ISSUES
-
$230,000 Oct 20, 2021 Issue: HEALTH ISSUES
-
$220,000 Jul 20, 2021 Issue: HEALTH ISSUES
-
$220,000 Apr 19, 2021 Issue: HEALTH ISSUES
-
$220,000 Jan 20, 2021 Issue: HEALTH ISSUES
-
$240,000 Oct 20, 2020 Issue: HEALTH ISSUES
-
$240,000 Jul 20, 2020 Issue: HEALTH ISSUES
-
$220,000 Apr 20, 2020 Issue: HEALTH ISSUES
-
$190,000 Jan 21, 2020 Issue: HEALTH ISSUES
-
$180,000 Oct 21, 2019 Issue: Health Issues
-
$320,000 Jul 22, 2019 Issue: Health Issues
-
$300,000 Apr 22, 2019 Issue: Health Issues
-
$20,000 Jan 22, 2019 Issue: Medicare/Medicaid Health Issues
-
$60,000 Jan 17, 2019 Issue: Health Issues
-
$60,000 Oct 09, 2018 Issue: Health Issues
-
$60,000 Jul 18, 2018 Issue: Health Issues
-
$50,000 Apr 19, 2018 Issue: Health Issues
New patents grants
Federal grants, loans, and purchases
Followers on EXEL's company Twitter account
Number of mentions of EXEL in WallStreetBets Daily Discussion
Recent insights relating to EXEL
Recent picks made for EXEL stock on CNBC
ETFs with the largest estimated holdings in EXEL
Flights by private jets registered to EXEL